Trial record 1 of 1 for:
Debio_0123-SCLC-104
Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05815160 |
|
Recruitment Status :
Recruiting
First Posted : April 18, 2023
Last Update Posted : January 26, 2024
|
Sponsor:
Debiopharm International SA
Information provided by (Responsible Party):
Debiopharm International SA
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2026 |
| Estimated Study Completion Date : | April 2026 |